ICM
IBEX icon

Invenomic Capital Management’s IBEX IBEX Stock Holding History

Invenomic Capital Management’s Portfolio IBEX Stock Details IBEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58,361
Closed -$719K – 166
2022
Q1 		$719K Buy
58,361
+3,727
+7% +$55.6K 0.08% 141
2021
Q4 		$705K Buy
+54,634
New +$867K 0.15% 122

Other funds holding IBEX

American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Invenomic Capital Management's IBEX Position: Q2 2022 in Review

Invenomic Capital Management sold out of IBEX (IBEX) in Q2 2022, closing a stake of 58,361 shares — an estimated $719K sold.

Invenomic Capital Management first reported a position in IBEX in Q4 2021 and held it in 2 quarters. The position peaked at $719K in Q1 2022. 45 funds tracked by Wall St. Rank hold IBEX as of Q2 2022.

  • Invenomic Capital Management reported no remaining IBEX position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 58,361 IBEX shares in Q2 2022, an estimated $719K.
  • Invenomic Capital Management first reported a position in IBEX in Q4 2021 and held it in 2 quarters.
  • Invenomic Capital Management's IBEX position peaked at $719K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held IBEX as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.